Search Results - "Fejfarova, V."

Both autologous bone marrow mononuclear cell and peripheral blood progenitor cell therapies similarly improve ischaemia in patients with diabetic foot in comparison with control treatment by Dubsky, M., Jirkovska, A., Bem, R., Fejfarova, V., Pagacova, L., Sixta, B., Varga, M., Langkramer, S., Sykova, E., Jude, E. B.

“…Background The aim of our study was to compare the effect of bone marrow mononuclear cell and peripheral blood progenitor cell therapies in patients with…”
Get full text

Factors Influencing the Risk of Major Amputation in Patients with Diabetic Foot Ulcers Treated by Autologous Cell Therapy by Husakova, J., Bem, R., Fejfarova, V., Jirkovska, A., Woskova, V., Jarosikova, R., Lovasova, V., Jude, E. B., Dubsky, M.

“…Introduction. Autologous cell therapy (ACT) is one of the last options for limb salvage in patients with chronic limb-threatening ischemia (CLTI) and diabetic…”
Get full text

Perfusion scintigraphy in the assessment of autologous cell therapy in diabetic patients with critical limb ischemia by Nemcova, A, Jirkovska, A, Dubsky, M, Bem, R, Fejfarova, V, Woskova, V, Pysna, A, Buncova, M

“…Perfusion scintigraphy with technetium-99-methoxy-isobutyl-isonitrile ((99m)Tc-MIBI) is often used for assessing myocardial function but the number of studies…”
Get full text

Impact of severe diabetic kidney disease on the clinical outcome of autologous cell therapy in people with diabetes and critical limb ischaemia by Dubský, M., Jirkovská, A., Bem, R., Němcová, A., Fejfarová, V., Hazdrová, J., Sutoris, K., Chlupáč, J., Skibová, J., Jude, E. B.

“…Aim To assess the impact of autologous cell therapy on critical limb ischaemia in people with diabetes and diabetic kidney disease. Methods A total of 59…”
Get full text

Incidence and Risk Factors of Diabetic Foot Syndrome in Patients Early After Pancreas or Kidney/Pancreas Transplantation and its Association with Preventive Measures by Vrátná, E., Husáková, J., Králová, K., Kratochvílová, S., Girman, P., Saudek, F., Dubský, M., Bém, R., Wosková, V., Jirkovská, A., Dad'ová, K., Vařeková, J, Lánská, V., Fejfarová, V.

“…Diabetic foot (DF) can develop in diabetic patients after organ transplantation (Tx) due to several factors including peripheral arterial disease (PAD),…”
Get full text

Clinical and (31)P magnetic resonance spectroscopy characterization of patients with critical limb ischemia before and after autologous cell therapy by Dubský, M, Šedivý, P, Němcová, A, Drobný, M, Hazdrová, J, Fejfarová, V, Bém, R, Jirkovská, A, Dezortová, M, Hájek, M

“…Autologous cell therapy (ACT) is a new treatment method for diabetic patients with critical limb ischemia (CLI) not eligible for standard revascularization…”
Get full text

Intranasal Calcitonin in the Treatment of Acute Charcot Neuroosteoarthropathy: A randomized controlled trial by Bem, Robert, Jirkovská, Alexandra, Fejfarová, Vladimíra, Skibová, Jelena, Jude, Edward B

“…Acute CNO was defined by clinical signs: warm, swollen foot and skin temperatures ≥2°C at the site of maximum deformity of the affected foot compared with a…”
Get full text

Hyperglycemia downregulates total lipoprotein lipase activity in humans by Kovár, J, Fejfarová, V, Pelikánová, T, Poledne, R

“…To address the question whether an increase in insulinemia and/or glycemia affects the total activity of lipoprotein lipase (LPL) in circulation, the enzyme…”
Get full text

Chronic Venous Disease and Its Intersections With Diabetes Mellitus by Jarošíková, R, Roztočil, K, Husáková, J, Dubský, M, Bém, R, Wosková, V, Fejfarová, V

“…Chronic venous disease (CVD) is a vascular disorder in which blood return is severely compromised and CVD is usually characterized by venous hypertension…”
Get full text

Clinical and 31P Magnetic Resonance Spectroscopy Characterization of Patients With Critical Limb Ischemia Before and After Autologous Cell Therapy by Dubský, M, Šedivý, P, Němcová, A, Drobný, M, Hazdrová, J, Fejfarová, V, Bém, R, Jirkovská, A, Dezortová, M, Hájek, M

“…Autologous cell therapy (ACT) is a new treatment method for diabetic patients with critical limb ischemia (CLI) not eligible for standard revascularization…”
Get full text

Special contact splints in postoperative care for patients with the diabetic foot by Fejfarová, V, Jirkovská, A, Bém, R, Dubský, M, Wosková, V, Němcová, A, Křížová, M, Niklová, J, Caňkářová, O

“…Adequate stabilization and off-loading of the lower limb is an integral part of postoperative care for patients with the diabetic foot. Off-loading can…”
Get more information

Treatment of critical limb ischemia and diabetic foot disease by the use of autologous stem cells by Dubský, M, Jirkovská, A, Bém, R, Pagácová, L, Fejfarová, V, Varga, M, Skibová, J, Langkramer, S, Syková, E

“…The aim of our study was to assess safety and effectiveness of therapy of critical limb ischaemia by autologous stem cells and evaluation of potential adverse…”
Get more information

Impariment of polymorphonuclear leukocyte function and diabetes control in patients with diabetic foot by Jirkovská, A, Fejfarová, V, Hosová, J, Kalanin, J, Stříž, I, Skibová, J

Get full text

The long-term efficacy of an educational program for patients with type 2 diabetes mellitus by Fejfarová, V., Jirkovská, A., Havlová, V., Hosová, J., Mašková, J., Skibová, J.

Get full text

Pathogen resistance and other risk factors in the frequency of lower limb amputations in patients with the diabetic foot syndrome by Fejfarová, V, Jirkovská, A, Skibová, J, Petkov, V

“…Patients with diabetes mellitus undergo more amputations due to peripheral vascular disease, neuropathy and especially to infection requiring long-lasting…”
Get more information

Analysis of the inflammation reaction and selected indicators of immunity in patients with an infected diabetic ulcer by Jirkovská, A, Fejfarová, V, Hosová, J, Stríz, I, Kalanin, J, Skibová, J

“…Patients with diabetes represent 50 to 70% of patients who undergo nontraumatic foot or leg amputation, caused mostly by infection and necrosis of soft tissues…”
Get more information

Non-specific immune responses in patients with chronic diabetic foot syndrome and chronic bacterial infection by Jirkovská, A, Fejfarová, V, Hosová, J, Kalanin, J, Stríz, I, Skibová, J

“…Chronic bacterial ulcers infection is a frequent cause of non-healing diabetic foot. The major factors of a non-specific immune response are phagocytic cells…”
Get more information

Effect of hyperinsulineamia and/or hyperglycaemia on the rate of triglyceride clearance from circulation by Kovář, J., Fejfarová, V., Pelikánová, T., Poledne, R.

Get full text